Cameron E Alexander1, Stuart Gowland2, Jon Cadwallader3, John M Reynard4, Benjamin W Turney4. 1. Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland. 2. Mobile Medical Technology, Christchurch, New Zealand. 3. Mobile Medical Technology, Auckland, New Zealand. 4. Oxford Stone Group, Department of Urology, Nuffield Department of Surgical Sciences, The Churchill Hospital, Oxford, England.
Abstract
OBJECTIVES: To present the national outcomes for New Zealand of over 9000 stone cases treated with SWL at 21 centres over a 20 year period. SUBJECTS/PATIENTS AND METHODS: Stone cases treated with SWL on board the Mobile Medical Technology (MMT) vehicle between 19 June 1995 and 1 December 2014 were identified, and data collection undertaken prospectively for patient, stone and treatment characteristics, and retrospectively for treatment outcomes. The primary outcome was treatment success, defined as complete stone clearance or clinically insignificant residual fragments (CIRFs) of ≤4 mm. Secondary outcomes were stone free rate, complications and auxiliary procedures, and all statistical analyses were descriptive. RESULTS: 9538 stone cases (7769 patients) were included. The overall, cumulative success rate was 58.7%; this included 45.1% that were stone free and 13.5% in which there were CIRFs ≤4 mm. Success rates varied widely by stone size and location. Overall rates of urinary tract infection, perinephric haematoma, hospital admission and ureteral stent placement were 1.1%, 0.2%, 6.8% and 4.1%, respectively. Variations in SWL protocols across centres limits the overall reliability of our findings. CONCLUSION: SWL remains a low morbidity management option requiring careful patient selection. This study provides valuable data for patient counseling and the formation of evidence based guidelines in SWL. The MMT SWL service has demonstrated that is it possible to deliver a high volume specialist stone service without requiring patients to travel further for treatment.
OBJECTIVES: To present the national outcomes for New Zealand of over 9000 stone cases treated with SWL at 21 centres over a 20 year period. SUBJECTS/PATIENTS AND METHODS: Stone cases treated with SWL on board the Mobile Medical Technology (MMT) vehicle between 19 June 1995 and 1 December 2014 were identified, and data collection undertaken prospectively for patient, stone and treatment characteristics, and retrospectively for treatment outcomes. The primary outcome was treatment success, defined as complete stone clearance or clinically insignificant residual fragments (CIRFs) of ≤4 mm. Secondary outcomes were stone free rate, complications and auxiliary procedures, and all statistical analyses were descriptive. RESULTS: 9538 stone cases (7769 patients) were included. The overall, cumulative success rate was 58.7%; this included 45.1% that were stone free and 13.5% in which there were CIRFs ≤4 mm. Success rates varied widely by stone size and location. Overall rates of urinary tract infection, perinephric haematoma, hospital admission and ureteral stent placement were 1.1%, 0.2%, 6.8% and 4.1%, respectively. Variations in SWL protocols across centres limits the overall reliability of our findings. CONCLUSION: SWL remains a low morbidity management option requiring careful patient selection. This study provides valuable data for patient counseling and the formation of evidence based guidelines in SWL. The MMT SWL service has demonstrated that is it possible to deliver a high volume specialist stone service without requiring patients to travel further for treatment.
Authors: Theodoros Tokas; Martin Habicher; Daniel Junker; Thomas Herrmann; Jan Peter Jessen; Thomas Knoll; Udo Nagele Journal: World J Urol Date: 2016-10-13 Impact factor: 4.226
Authors: Danny M Rabah; Mohamed S Mabrouki; Karim H Farhat; Mohamed A Seida; Mostafa A Arafa; Riyadh F Talic Journal: Urolithiasis Date: 2016-09-29 Impact factor: 3.436
Authors: Jonathan D Harper; James E Lingeman; Robert M Sweet; Ian S Metzler; Peter L Sunaryo; James C Williams; Adam D Maxwell; Jeff Thiel; Bryan W Cunitz; Barbrina Dunmire; Michael R Bailey; Mathew D Sorensen Journal: J Urol Date: 2022-03-21 Impact factor: 7.600
Authors: Patrick Juliebø-Jones; Etienne Xavier Keller; Thomas Tailly; Mathias Sørstrand Æsøy; Francesco Esperto; Ioannis Mykoniatis; Vincent de Coninck; Amelia Pietropaolo Journal: World J Urol Date: 2021-11-17 Impact factor: 4.226